News

News selection

In the following you will find news from Polypharma Technologies & Sciences GmbH and the pharmaceutical industry.

Polypharma project planning for MENA pharma facilities

Polypharma project planning for MENA pharma facilities

Core competencies of Polypharma include project planning, feasibility studies, plant construction, technology transfer, pharmaceutical development, and materials sourcing and supply. Its full service offerings can include all these elements to provide a total solution for pharmaceutical developers and producers that can also include processing registrations, with on-site services that include all necessary API-manufacturer documentation, such as GMP, CPP, manufacturing license, and Drug Master...

read more
Polypharma marks World Cholesterol Day

Polypharma marks World Cholesterol Day

Hamburg, Germany: Specialist pharmaceutical consultant and supplier Polypharma Technologies & Sciences GmbH (Polypharma) has been marking international Cholesterol Day. The substance cholesterol is involved in metabolic processes in the body, primarily in the metabolization of fat. The body covers its need for cholesterol by producing it in the liver and taking it from food. If excessive cholesterol circulates in the body, it accumulates in the vascular walls and facilitates the occurrence...

read more
Polypharma project planning for MENA pharma facilities

Polypharma celebrates 30th Anniversary

Single partner Polypharma offers a unique blend of services and skills that make it possible for it to act as a single partner accompanying local companies all the way from selection of target product through to actual receipt of raw materials for production. “Over the years we have developed more than 200 approved drug dossiers for our partners, meeting real local needs, along with tech transfer and up-scaling services to succeed with their own production,” noted Polypharma founder and...

read more

Why Polypharma cannot recommend its partners to package purchased bulk medicines

Many new customers find it interesting to pack already manufactured goods as a first step before producing their own medicines. Here are the reasons why Polypharma cannot recommend buying bulk medicines: From a pharmaceutical point of view, production and packaging in a GMP-compliant production line is the highest priority for the quality of the pharmaceuticals Only with self-produced goods can you be 100% sure of the quality of the finished product If the manufacturing process and subsequent...

read more

CPhI Worldwide 2020 in Milan

The CPhI worldwide 2020 in Milan in October 2020 was postponed to 2021 due to the COVID-19 pandemic. We would still like to keep in touch with you and invite you to participate in meetings via videoconference.https://www.cphi.com/europe/

read more

Polypharma
Technologies & Sciences GmbH

Grosse Reichenstrasse 27
20457 Hamburg
Germany
+49 (0)40 37 480 3-0
info[at]polypharma.de